Using AI in Pharma R&D and Clinical Testing—Regulatory and Legal Issues for the US Landscape

Watch the presentation >>  |  View the slides in English >>  |  View the slides in Japanese >>

Wednesday, January 19, 2022
10:00 AM - 11:00 AM Japan Standard Time
09:00 AM - 10:00 AM China Standard Time
Tuesday, January 18, 2022
08:00 PM - 09:00 PM Eastern Standard Time
05:00 PM - 06:00 PM Pacific Standard Time

In this session, partners Kathleen Sanzo, Jacqueline Berman, Nancy Yamaguchi, and Jitsuro Morishita will explain how the biopharma industry is using AI to increase efficiencies during the drug development process, explore the legal and regulatory implications of AI’s application to clinical trials, and discuss the potential future of AI in the Food and Drug Administration’s drug and biologic divisions.